constipation while taking semaglutide Why Matters on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of GLP-1 and GIP-1 agonists like (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead Ozempic constipation: How to treat

Key timing considerations: Broader Tmax window (8 to 72 hours) means less precision in predicting peak effects Dual GIP/GLP-1 mechanism may produce a different side effect timing pattern than pure GLP-1 agonists Body aches and muscle pain may peak later than GI symptoms, around 24 to 48 hours post-injection Consider how tirzepatide affects metabolism throughout the weekly cycle The appetite suppression timeline may differ from semaglutide due to the dual mechanism Dose escalation timing: Tirzepatide starts at 2.5mg weekly, escalating to 5mg after 4 weeks

Novo Nordisk, which makes Ozempic and Wegovy, and Eli Lilly, which makes Mounjaro and Zepbound, stress that the drugs are meant to be used alongside a healthy diet and exercise

Resources like SeekPeptides provide updated protocols, dosing charts , and community experiences that evolve as more real-world data becomes available

If youre considering compounded semaglutide, choose a provider that partners with 503A or 503B pharmacies, requires third-party testing for potency and sterility, and is LegitScript certified

Additionally, all THINNR medications and supplements are put through extensive post-production quantitative testing to ensure product specification, potency, and safety are met before being released and made available for sale

Do NOT increase dose early, even if benefits are not seen this dose is only for acclimatization